| Project 1, Study 2: Extended Exposure to Low Nicotine Content Cigarettes in Childbearing Age Women (NCT02250534) | University of Vermont | 2016-10-01 |
| Surface Roughness of Heat Cured Acrylic Resin Versus Acrylic Resin With Titanium Dioxide (NCT02950584) | Cairo University | 2016-10-01 |
| A Clinical Research of CD33-Targeted CAR-T in Myeloid Malignancies (NCT02958397) | Southwest Hospital, China | 2016-10-01 |
| Studies of the Safety and Immunogenicity of a Sabin Inactivated Poliovirus Vaccine (NCT02985320) | Sinovac Biotech Co., Ltd | 2016-10-01 |
| A Study of ME-401 in Subjects With CLL/SLL, FL, and B-cell Non Hodgkin's Lymphoma (NCT02914938) | MEI Pharma, Inc. | 2016-10-01 |
| Pharmacokinetics, Safety and Tolerability Study of Single Dose of Abatacept 125mg Administered Subcutaneously (NCT02805010) | Jiangsu Simcere Pharmaceutical Co., Ltd. | 2016-10-01 |
| Anti-CD19 CAR T Infusion Combined With Allogeneic Stem Cell Transplantation for B-cell Leukemia/Lymphoma (NCT03110640) | First Affiliated Hospital of Wenzhou Medical University | 2016-10-01 |
| A Clinical Research of CD22-Targeted CAR-T in B Cell Malignancies (NCT02935153) | Southwest Hospital, China | 2016-10-01 |
| A Trial to Compare Post Prandial Blood Glucose Control of BioChaperone® Combo With Humalog® Mix25 and With Simultaneous Injections of Humalog® and Lantus® in Subjects With Type 2 Diabetes (NCT02915250) | Adocia | 2016-10-01 |
| A Comparative, Pharmacokinetic Study of CB-839 Capsule and Tablet Formulations in Healthy Adults (NCT02944435) | Calithera Biosciences, Inc | 2016-10-01 |
| First-in-human Evaluation of the SELUTION DCB, a Novel Sirolimus Coated Balloon in Peripheral Arteries (NCT02941224) | M.A. Med Alliance S.A. | 2016-10-01 |
| Extension Study Evaluating Long Term Safety and Activity of AGT-181 in Children With MPS I (NCT03071341) | ArmaGen, Inc | 2016-10-01 |
| Decitabine Plus R-CHOP in Diffuse Large B-cell Lymphoma (NCT02951728) | Ruijin Hospital | 2016-10-01 |
| MAD Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Cavosonstat (N91115) in Healthy Subjects (SNO-9) (NCT02934139) | Nivalis Therapeutics, Inc. | 2016-10-01 |
| Fully Automated Anesthesia, Analgesia and Fluid Management (NCT02886806) | Erasme University Hospital | 2016-10-01 |
| Dasatinib and Osimertinib (AZD9291) in Advanced Non-Small Cell Lung Cancer With EGFR Mutations (NCT02954523) | Chul Kim | 2016-10-01 |
| Neoadjuvant Combination Biotherapy With Ipilimumab and Nivolumab or Nivolumab Alone (NCT02736123) | University of Pittsburgh | 2016-10-01 |
| Phase 1b/2 Study Testing Radium-223 Dichloride/Bortezomib/Dexamethasone Combination in Relapsed Multiple Myeloma (NCT02605356) | Bayer | 2016-10-01 |
| Rituximab, Romidepsin, and Lenalidomide in Treating Patients With Recurrent or Refractory B-cell Non-Hodgkin Lymphoma (NCT02281279) | Mayo Clinic | 2016-10-01 |
| Safety Study and Therapeutic Effects of Umbilical Cord Blood Treg on Autoimmune Diabetes (NCT02932826) | Second Xiangya Hospital of Central South University | 2016-10-01 |
| A Study to Evaluate the Bioavailability, Safety and Tolerability of a Solid Dosage Formulation Relative to a Suspension of JNJ-54175446 in Healthy Male and Female Participants (NCT02930694) | Janssen Research & Development, LLC | 2016-10-01 |
| Project 2, Study 2: Extended Exposure to Low Nicotine Content Cigarettes in Opioid Abusers (NCT02250664) | University of Vermont | 2016-10-01 |
| The Safety and Efficacy of Jobelyn in the Treatment of Breast Cancer Patients (NCT01936064) | Lagos State University | 2016-10-01 |
| The Influence of Plaquenil/Hydroxychloroquine (HCQ) on Insulin Secretion (NCT02910076) | Hadassah Medical Organization | 2016-10-01 |
| Phase I Study for SynGEM, an Intranasal Respiratory Syncytial Virus (RSV) Prefusion F Subunit Candidate Vaccine (NCT02958540) | Mucosis BV | 2016-10-01 |
| Use of Autologous, Adult Adipose-Derived Stem/Stromal Cells In Chronic Lung Disorders (NCT02946658) | Healeon Medical Inc | 2016-10-01 |
| Effects of IV-Administered Ca-DTPA and Zn-DTPA To Treat Patients With Gadolinium Deposition Disease (NCT02947022) | University of North Carolina, Chapel Hill | 2016-10-01 |
| A Clinical Trial of Patients With Melanoma (NCT02915666) | University of Texas Southwestern Medical Center | 2016-10-01 |
| Prevention of Skeletal Muscle Adaptations to Traumatic Knee Injury and Surgery (NCT02945553) | University of Vermont | 2016-10-01 |
| Study to Evaluate Safety, Tolerability and Pharmacokinetics of GSK2269557 to Japanese Healthy Subjects (NCT02972905) | GlaxoSmithKline | 2016-10-01 |
| RNA-Immunotherapy of IVAC_W_bre1_uID and IVAC_M_uID (NCT02316457) | BioNTech SE | 2016-10-01 |
| Safety Study to Assess AFM11 in Patients With Relapsed or Refractory Adult B-precursor ALL (NCT02848911) | Affimed GmbH | 2016-10-01 |
| Study to Evaluate the Effect of Diltiazem Extended Release on the Pharmacokinetics of E2027 in Healthy Subjects (NCT02947711) | Eisai Co., Ltd. | 2016-10-01 |
| Voclosporin in Healthy Japanese Volunteers (NCT02949999) | Aurinia Pharmaceuticals Inc. | 2016-10-01 |
| Collaborative Power Mobility Innovative Learning OpporTunity (CoPILOT) - A Pilot Study of a New Training Approach (Phase 1) (NCT02320786) | University of British Columbia | 2016-10-01 |
| New Formulations of Propafenone to Treat Atrial Fibrillation (NCT02710669) | Vanderbilt University | 2016-10-01 |
| Assessment of Pharmacokinetics (PK) and Safety of M834 and Orencia ®, in Healthy Subjects (NCT02923583) | Momenta Pharmaceuticals, Inc. | 2016-10-01 |
| DCB-DM101 in Healthy Volunteers and for Type 2 Diabetes Mellitus Patients (NCT03033433) | VitNovo, Inc. | 2016-10-01 |
| Study of Sting Challenge and Serological Responses to Jack Jumper Venom Immunotherapy With Inulin as Adjuvant (Jumpvax) (NCT03066986) | Central Adelaide Local Health Network Incorporated | 2016-10-01 |
| Sidlenafil in Combination With Oral Anticoagulants in Patients With Intermediate-high Risk of Pulmonary Embolism (NCT02946944) | Meshalkin Research Institute of Pathology of Circulation | 2016-10-01 |
| Dose-finding, Safety and Efficacy Study of Radium-223 Dichloride (XOFIGO) in RCC Patients With Bone Metastases. (EIFFEL) (NCT02880943) | Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie | 2016-10-01 |
| A Bio-equivalence Study of Sofosbuvir From Sofodelevier 400 mg Film Coated Tablets (Al-debeiky Pharma, Egypt) Versus Sovaldi 400 mg Tablets (Gilead Sciences, Canada) (NCT03062423) | Genuine Research Center, Egypt | 2016-10-01 |
| Trial of CUDC-907 in Children and Young Adults With Relapsed or Refractory Solid Tumors, CNS Tumors, or Lymphoma (NCT02909777) | Dana-Farber Cancer Institute | 2016-10-01 |
| Near-Infrared Fluorescence Guided Robotic Pulmonary Segmentectomy for Early Stage Lung Cancer (NCT02570815) | St. Joseph's Healthcare Hamilton | 2016-10-01 |
| A Study in Healthy Volunteers to Assess Immune Response to Multiple Injections of Filgrastim Hospira or Neupogen Reference Product. (NCT02923791) | Pfizer | 2016-10-01 |
| High Dose Carfilzomib for Newly Diagnosed Myeloma (NCT02937571) | Memorial Sloan Kettering Cancer Center | 2016-10-01 |
| A Personal Cancer Vaccine (NEO-PV-01) w/ Nivolumab for Patients With Melanoma, Lung Cancer or Bladder Cancer (NCT02897765) | BioNTech US Inc. | 2016-10-01 |
| CAR-pNK Cell Immunotherapy for Relapsed/Refractory CD33+ AML (NCT02944162) | PersonGen BioTherapeutics (Suzhou) Co., Ltd. | 2016-10-01 |
| Burst Suppression Anesthesia for Treatment of Severe Depression (NCT02935647) | University of Utah | 2016-10-01 |
| Study to Evaluate the Safety, Biodistribution, Radiation Dosimetry and Tumor Imaging Potential of [131I]-SGMIB Anti-HER2 VHH1 in Healthy Volunteers and Breast Cancer Patients (NCT02683083) | Precirix | 2016-10-01 |
| Study of Volasertib and Belinostat in Patients With Relapsed and Refractory Aggressive B-cell and T-cell Lymphomas (NCT02875002) | Yale University | 2016-10-01 |
| Study of DS-8273a With Nivolumab in Unresectable Stage III or Stage IV Melanoma (NCT02983006) | NYU Langone Health | 2016-10-01 |
| Stem Cell Transplantation in Cirrhotic Patients (NCT02943889) | Assiut University | 2016-10-01 |
| Safety and Dose Finding Study of Neratinib in Children and Young Adults With Cancer That Has Returned or Not Responded to Treatment (NCT02932280) | Memorial Sloan Kettering Cancer Center | 2016-10-01 |
| The Effect of PAS on the Pharmacokinetics of Tenofovir in Healthy Subjects (NCT03070405) | Inje University | 2016-10-01 |
| Neuroscience of Marijuana Impaired Driving (NCT02757313) | Yale University | 2016-10-01 |
| Hysteroscopic Tubal Occlusion Using Iso-Amyl 2-Cyano Acrylate (Amcrylate) in Patients With Hydrosalpinx (NCT02977234) | Ain Shams University | 2016-10-01 |
| First Line Bio-immunotherapy With Thymosin Alpha 1 in Patients With Sensitizing EGFR Mutation Positive Non Small Cell Lung Cancer Who Are Taking Standard of Care Therapy (NCT02906163) | SciClone Pharmaceuticals | 2016-10-01 |
| Optimization of a Tenofovir Enema for HIV Prevention (NCT02750540) | Johns Hopkins University | 2016-10-01 |
| Effect of Neostigmine on the Recovery of Rocuronium: A Comparison Between Partial and TOF Ratio-Based Dose (NCT03058263) | Indonesia University | 2016-10-01 |
| Premedication With Nebulized Ketamine,Dexmedetomidine Versus Midazolam in Oncologic Preschool Children (NCT02935959) | Assiut University | 2016-10-01 |
| Response to Intermittent Pneumatic Compression Therapy in Head and Neck Cancer-Related Lymphedema (NCT02946021) | Tactile Medical | 2016-10-01 |
| Study of ASN003 in Subjects With Advanced Solid Tumors (NCT02961283) | Asana BioSciences | 2016-10-01 |
| Safety and Efficacy Study of Intravesical Instillations of BotuGelTM, Slow Release RTGel Based Botox® Formulations, in Idiopathic OAB Patients With Urinary Incontinence ("INTIMO2") (NCT02674269) | UroGen Pharma Ltd. | 2016-10-01 |
| Special Combination of BBI608 and Pembrolizumab (NCT02851004) | Takayuki Yoshino | 2016-10-01 |
| Facilitating the Behavioral Treatment of Cannabis Use Disorder (NCT02946489) | New York State Psychiatric Institute | 2016-10-01 |
| A Study to Assess the pharmacoMRI Effects of AUT00206 in Healthy Males (NCT02935725) | Autifony Therapeutics Limited | 2016-10-01 |
| Safety and Tolerability Evaluation Study of BVAC-C in Patients With HPV Type 16 or 18 Positive Cervical Cancer (NCT02866006) | Cellid Co., Ltd. | 2016-10-01 |
| Study in Patients With SCLC of Veliparib in Combination With Topotecan (NCT03227016) | Central European Society for Anticancer Drug Research | 2016-10-01 |
| Trial of ZW25 (Zanidatamab) in Patients With Advanced HER2-expressing Cancers (NCT02892123) | Jazz Pharmaceuticals | 2016-09-30 |
| Onalespib and CDKI AT7519 in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery (NCT02503709) | National Cancer Institute (NCI) | 2016-09-30 |
| Study of Cobimetinib in Combination With Atezolizumab and Bevacizumab in Participants With Gastrointestinal and Other Tumors (NCT02876224) | Hoffmann-La Roche | 2016-09-30 |
| Selective HDAC6 Inhibitor ACY-241 in Combination With Ipilimumab and Nivolumab (NCT02935790) | Celgene | 2016-09-30 |
| An Open-Label Pharmacokinetics and Safety Study of Talazoparib (MDV3800) (NCT02997176) | Pfizer | 2016-09-30 |
| A Phase I Study to Evaluate Pharmacokinetics, Efficacy and Safety of CT-P13 Subcutaneous in Patients With Active Crohn's Disease and Ulcerative Colitis (NCT02883452) | Celltrion | 2016-09-29 |
| Oxidative Phosphorylation Inhibitor IACS-010759 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia (NCT02882321) | M.D. Anderson Cancer Center | 2016-09-29 |
| Enhanced Epidermal Antigen Specific Immunotherapy Trial -1 (NCT02837094) | Cardiff University | 2016-09-29 |
| Study of Safety and Efficacy of KTE-C19 in Combination With Atezolizumab in Adults With Refractory Diffuse Large B-Cell Lymphoma (DLBCL) (NCT02926833) | Kite, A Gilead Company | 2016-09-29 |
| A Study of LY3214996 Administered Alone or in Combination With Other Agents in Participants With Advanced/Metastatic Cancer (NCT02857270) | Eli Lilly and Company | 2016-09-29 |
| Single Rising Dose Study of BI 690517 in Healthy Volunteers (NCT02891148) | Boehringer Ingelheim | 2016-09-29 |
| Drug-Drug Interaction Study Between DWC20155 / DWC20156 and DWC20161 in Healthy Volunteers (NCT02947139) | Daewoong Pharmaceutical Co. LTD. | 2016-09-29 |
| Safety Study of Human Milk Oligosaccharides in Healthy Adults (NCT05516225) | Prolacta Bioscience | 2016-09-29 |
| Comparative Pharmacokinetic Study of Lidocaine Patch 1.8% (ZTlido™) and Lidocaine Patch 5% (Lidoderm®) in Healthy Subjects (NCT04149938) | Scilex Pharmaceuticals, Inc. | 2016-09-28 |
| Study of Pts With Philadelphia Chromosome-Pos ALL With Comb of Ibrutinib, Dasatinib, and Prednisone (NCT02815059) | University of Utah | 2016-09-28 |
| Evaluation Study of the Bioavailability of Brexpiprazole Orally Disintegrating Tablets in Healthy Male Subjects (NCT02875080) | Otsuka Pharmaceutical Co., Ltd. | 2016-09-27 |
| A Single Dose Study of E6130 in Japanese Healthy Adult Male Subjects (NCT02902978) | EA Pharma Co., Ltd. | 2016-09-26 |
| Dose Escalation Study of JNJ-54767414 (Daratumumab) in Chinese Participants With Relapsed or Refractory Multiple Myeloma Who Failed at Least 2 Prior Lines of Systemic Therapy (NCT02852837) | Janssen Research & Development, LLC | 2016-09-26 |
| Safety and Efficacy of Metronomic Cyclophosphamide, Metformin and Olaparib in Endometrial Cancer Patients (NCT02755844) | Hospices Civils de Lyon | 2016-09-23 |
| A Thorough QTc Trial Evaluating the Effect of SNAC on Cardiac Repolarisation in Healthy Male Subjects. (NCT02911870) | Novo Nordisk A/S | 2016-09-23 |
| Rovalpituzumab Tesirine in Delta-Like Protein 3-Expressing Advanced Solid Tumors (NCT02709889) | AbbVie | 2016-09-23 |
| Pharmacokinetics and Pharmacodynamics of 3 Dosages of Estriol After Continuous Vaginal Administration for 21 Days (NCT03363997) | Galeno Desenvolvimento de Pesquisas Clínicas | 2016-09-23 |
| Study to Evaluate the Pharmacokinetics of Firsocostat or Fenofibrate in Adults With Normal and Impaired Hepatic Function (NCT02891408) | Gilead Sciences | 2016-09-23 |
| Safety and Tolerability of Atezolizumab (ATZ) in Combination With Radium-223 Dichloride (R-223-D) in Metastatic Castrate-Resistant Prostate Cancer (CRPC) Progressed Following Treatment With an Androgen Pathway Inhibitor (NCT02814669) | Hoffmann-La Roche | 2016-09-23 |
| A Single Dose Study of SHR4640 in Healthy Male Volunteers (NCT03015948) | Atridia Pty Ltd. | 2016-09-22 |
| A Study of Prexasertib (LY2606368) in Participants With Advanced Cancer (NCT02778126) | Eli Lilly and Company | 2016-09-22 |
| Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of SKI-O-703 in Healthy Volunteers (NCT03315494) | Oscotec Inc. | 2016-09-22 |
| Pharmacokinetics and Safety of Evogliptin in Subjects With Hepatic Dysfunction (NCT02754219) | Dong-A ST Co., Ltd. | 2016-09-22 |
| A Phase 1/2, Open-Label, Dose Escalation, Safety and Tolerability Study of INCB050465 and Itacitinib in Subjects With Previously Treated B-Cell Malignancies (CITADEL-101) (NCT02018861) | Incyte Corporation | 2016-09-22 |
| A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Activity of Intravitreal LKA651 in Patients With Macular Edema (NCT02867735) | Novartis Pharmaceuticals | 2016-09-21 |
| A Study of Safety, Pharmacokinetics and Pharmacodynamics of JNJ-64457107 in Participants With Advanced Stage Tumors (NCT02829099) | Janssen Research & Development, LLC | 2016-09-21 |